Morgan Stanley Says Buy While Blood Is In The Streets – ValueWalk Premium
Morgan Stanley US growth

Morgan Stanley Says Buy While Blood Is In The Streets

Morgan Stanley sees recent growth fears as an opportunity to add exposure.

In a Cross-Asset Strategy research note dated October 14 reviewed by ValueWalk, the brokerage firm said that growth remains intact in the U.S. and they are recommending investments in U.S. high yield instruments, select emerging markets and the long-end of U.S. investment grade credit instruments.

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0